CRO Analytics announced that it is seeking sponsor and CRO partners to enroll in a limited Pilot to Production program
CRO Analytics, a provider of validated clinical trial performance data, announced that it is seeking sponsor and CRO partners to enroll in a limited Pilot to Production program of the biopharma industry’s first Clinical Trial Quality System (CTQS), Performer™.
Performer is a cloud-based software platform designed to improve clinical research by assessing clinical trial performance through a series of instruments developed over a two-year validation process. The online tools, which take less than five minutes to complete, measure the quality of more than 70 functional areas and professional skills involved in clinical trial delivery. The data is analyzed using a series of algorithms to deliver actionable insights through standard and custom reports to clinical trial teams, functional area leads, and executives.
Since completed assessment data is available immediately, Performer can be used to manage and respond to issues during trial, as well as provide performance analytics at the functional and corporate level. In addition, Performer enhances the value of existing operational and financial metrics by helping users’ better measure the quality associated with those numbers.
Pilot to Production seeks a limited number of sponsor and CRO partners to work over a six-month period with CRO Analytics to develop a deeper understanding of how Performer is used, adds value, and can be improved prior to its full launch next year. Dr. Michael Howley, co-founder and Chief Science Officer (CSO) of CRO Analytics and his team will meet with partners monthly to review the findings.
For the past two quarters, CRO Analytics has collaborated with Applied Clinical Trials to collect data for the first ever industry-wide outsourced clinical trial assessment.
Read the full release here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.